Hardware, Robotics & IoT VC Funds

.406 Ventures, based in Boston, is an early-stage venture capital firm with over $1.4 billion under management. Founded in 2005, the firm focuses on investments in healthcare, data and AI, and cybersecurity. .406 Ventures partners with visionary entrepreneurs to build pioneering companies, offering substantial operational support and leveraging extensive industry networks. The firm's investment strategy includes participating in the first institutional capital rounds, typically investing between $2 million and $5 million initially, with significant reserves for follow-on investments. Notable portfolio companies include AbleTo, Carbon Black, CloudHealth Technologies, and Iora Health, all of which have been acquired by major corporations. .406 Ventures emphasizes a hands-on approach, ensuring each portfolio company benefits from the collective experience of the entire investment team. This approach includes helping companies navigate challenges, optimize business strategies, and scale successfully. The firm aims to foster long-term partnerships, providing not just capital but also strategic guidance and operational expertise.

The Silicon Valley Technology Council (SVTC) operates as a key hub for fostering innovation and investment within the tech sector, particularly in the heart of Silicon Valley. With a strong focus on deep technology, SVTC aligns itself with the latest advancements in sectors like AI, quantum computing, and biotechnology. They work closely with tech leaders to address industry needs, supporting developments that can disrupt traditional models and foster significant growth. Their activities are driven by a mission to propel cutting-edge research into scalable businesses, ensuring the region remains a leader in global innovation. SVTC actively supports startups through partnerships and advocacy, emphasizing areas such as sustainability, ethical AI, and cybersecurity. They push for favorable regulatory environments that can accelerate the deployment of technologies like autonomous vehicles and clean energy solutions. By bringing together public and private stakeholders, the council ensures that Silicon Valley's tech ecosystem remains robust and well-connected. Furthermore, SVTC engages in promoting diversity and education, striving to enhance the local talent pool while also advocating for inclusive immigration policies to attract global tech expertise. Their recent initiatives include policy recommendations on AI, boosting funding for scientific research, and creating pathways for sustainable tech innovations. The council remains a pivotal player, providing insights, networking, and advocacy to ensure that Silicon Valley continues to be synonymous with tech entrepreneurship and growth.

10X Capital is a versatile alternative asset management firm headquartered in New York City, specializing in providing institutional investors access to high-growth opportunities across various asset classes. Founded by Hans Thomas and co-headed by David Weisburd, the firm aligns Wall Street with Silicon Valley, focusing on venture capital, private credit, private equity, and real estate investments. 10X Capital’s notable strategies include venture capital investments in high-growth technology companies through private equity and public markets. They also manage SPACs, IPOs, and securitization, leveraging a deep network and robust analytical capabilities to identify and nurture promising startups. The firm has successfully facilitated the growth of several technology-driven businesses, effectively bridging the gap between institutional capital and innovative ventures​. Key team members include Russell Read, Chief Investment Officer, who brings extensive experience from CalPERS and the Alaska Permanent Fund, and Guhan Kandasamy, Chief Data Officer, known for his expertise in credit risk and data management. The team’s diverse background enables 10X Capital to provide comprehensive support and strategic insights to their portfolio companies​​. The firm’s mission is to democratize access to capital markets, ensuring that high-potential ventures receive the necessary funding and support to scale efficiently. This commitment is evident in their broad range of services and their strategic focus on sectors like technology, real estate, and specialty finance

11.2 Capital is an early-stage venture capital firm based in San Francisco, focusing on breakthrough technologies in artificial intelligence, augmented reality/virtual reality (AR/VR), robotics, space, and data-driven health. They have built a diverse portfolio that includes companies such as Bay Labs, Deep Genomics, and Hinge Health. Their investment strategy centers on early-stage technology startups with the potential for significant impact. 11.2 Capital has made 51 investments, with notable exits including Cruise Automation and Kindred AI. They emphasize supporting companies that leverage data at molecular and behavioral levels to innovate in healthcare, such as Apixio and Hindsait, which use data to enhance patient care and reduce costs. The firm is led by a team with deep expertise in technology and investment. Shelley Zhuang, a notable figure in the venture capital world, brings extensive knowledge in cybersecurity and AI. 11.2 Capital's approach involves not only providing capital but also strategic support to help startups scale effectively. Overall, 11.2 Capital is dedicated to fostering innovation in tech-driven sectors, providing both financial backing and strategic partnerships to enable startups to reach their full potential​.

1517 Fund, co-founded in 2015 by Michael Gibson and Danielle Strachman, is a venture capital firm with a distinctive focus on backing young founders, dropouts, and renegade scientists. The firm is inspired by the spirit of Martin Luther's 1517 Reformation, challenging the conventional education system and supporting innovators working outside traditional academic tracks. 1517 Fund invests in early-stage startups, including those at the R&D/idea phase up to the Seed stage. They are particularly interested in software, hardware with a data play, deep tech/science fiction tech, and biotech. Their initial investments range from $50,000 to $1,000,000, with an average check size of around $400,000 for pre-seed investments. Notable companies in 1517 Fund's portfolio include Luminar, Lambda, Deepgram, and Figma. They have a community-oriented approach, providing grants, investments, and support to a network of hackers, makers, and scientists globally. This community includes events, workshops, and office hours aimed at fostering innovation and advancing the edges of knowledge and science. The fund's co-founders, Michael Gibson and Danielle Strachman, previously worked with Peter Thiel on the Thiel Fellowship, which provided $100k grants to young entrepreneurs, leading to successful ventures like Ethereum and OYO Rooms. This background underscores their commitment to nurturing unconventional talent and groundbreaking ideas.

1776 Ventures, based in Washington, D.C., is a seed-stage venture capital firm with a focus on transformative startups addressing critical societal needs. Notable investments include Twiga Foods, a Nairobi-based agriculture and e-commerce platform; MPOWER Financing, providing financial services for higher education; and HopSkipDrive, a transportation solution for children. The fund primarily invests in sectors like healthcare, education, energy, smart cities, and fintech. Geographically, 1776 Ventures has a diverse portfolio with significant activity in the United States, particularly in California, Washington D.C., and New York, as well as international investments in Kenya and Brazil. Their strategy emphasizes early-stage investments, mostly seed and occasionally Series A rounds. They prefer to follow rather than lead, with an average check size of $3 million and typically around ten rounds per year. The firm was co-founded by Donna Harris and Evan Burfield, who bring extensive expertise and networks to support portfolio companies. They actively seek startups with strong potential for social impact and scalability. To approach 1776 Ventures, it is beneficial to have a clear demonstration of market need and a scalable business model. For startups looking to engage with 1776 Ventures, highlighting innovation in complex and high-impact sectors is crucial. The firm values proactive outreach from founders who can articulate a clear vision and demonstrate a tangible plan for growth and impact​.

1955 Capital is a venture capital firm based in Los Altos, California, founded by Andrew Chung in 2015. The firm focuses on investing in advanced technologies from the Americas and Europe that can address significant challenges in developing countries, particularly in areas like energy, environment, food safety, health, education, and sustainable manufacturing. 1955 Capital’s investment strategy is driven by a mission to leverage breakthrough technologies to tackle some of the world’s most pressing issues. The firm aims to foster global partnerships, accelerate technology commercialization, and create substantial market opportunities. Their approach is deeply informed by the founder’s extensive experience in sustainability and health technologies, including involvement with several unicorns in these sectors during his time at Khosla Ventures. The firm has built a diverse portfolio, investing in companies that are pioneering innovative solutions across various industries. For instance, they have supported ventures in electric aviation, alternative proteins, energy storage, and surgical robotics. By focusing on these high-impact sectors, 1955 Capital seeks to create both financial returns and positive global change.

1984 Ventures, founded in 2018 and based in San Francisco, is a venture capital firm focusing on seed and early-stage investments in software businesses. The firm targets sectors such as fintech, healthcare, SaaS, e-commerce, and consumer technology. Their portfolio includes notable companies like Properly, Brace, and Heroes Jobs​. The firm has made 120 investments, with 9 successful exits to date, including Convex, which was acquired in 2024. 1984 Ventures has recently invested in companies like Fay, Collaborative Robotics, and Alaffia Health in 2024​. 1984 Ventures is led by founder and managing partner Ramy Adeeb, and they leverage their entrepreneurial experience to help portfolio companies grow. They emphasize supporting startups that apply technology to solve real-world problems​.

212 Angels, also known as 212 Ventures, is a leading venture capital firm focused on backing B2B technology startups that are ready to scale globally. Based in Istanbul, with additional offices in Doha, Dubai, and San Francisco, 212 has a strong regional presence but operates with a global perspective. The firm has invested in numerous innovative companies, supporting them through various stages of growth. Notable investments include Metrobi, a last-mile logistics platform, and Fazla, which provides tech-enabled solutions for waste management and has significantly reduced food waste and carbon emissions. Other key portfolio companies are Trio Mobil, which offers industrial IoT solutions, and AppSamurai, a mobile marketing technology firm. 212 Angels typically invests in seed to Series A rounds, with initial investments ranging from $500K to $5M. They focus on sectors like fintech, logistics, AI, and SaaS, providing both capital and strategic support to help startups expand internationally. Their approach emphasizes a hands-on partnership with founders, leveraging their extensive network and expertise to drive growth. The leadership team, including founder and managing director Ali Karabey, brings a wealth of experience in venture capital and entrepreneurship. They pride themselves on their ability to identify and nurture high-potential startups, helping them navigate the challenges of scaling and achieving global success. For startups looking to attract investment from 212 Angels, it’s crucial to demonstrate a strong product-market fit and potential for international growth. The firm values innovation, scalability, and the ability to solve significant problems in their respective industries.

2048 Ventures is a venture capital firm founded in 2018 and headquartered in New York, NY. The firm focuses on early-stage investments, particularly in technology-driven startups. They have a strong portfolio with over 120 investments across diverse sectors, including biotechnology, artificial intelligence, health tech, and commercial products. Some notable companies backed by 2048 Ventures include Adaptis Technologies, an AI-powered platform for optimizing the carbon footprint of buildings, and Fathom Optics, which delivers 3D experiences using standard printing technologies. Their investment strategy is to support visionary founders at the earliest stages, often leading pre-seed and seed rounds. 2048 Ventures has shown significant activity, with their portfolio companies collectively raising $591 million and reaching a valuation of $2.6 billion by the end of 2023. They have invested in innovative companies like TwoStep Therapeutics, which specializes in modular peptide technology for targeting solid tumors, and Century Health, which leverages AI to accelerate drug development​.

2150 is a London, Copenhagen, and Berlin-based venture capital firm focused on transforming urban environments through sustainable technology. With a €268 million fund, 2150 invests in companies that address major challenges across the "Urban Stack"—everything from the design and construction of cities to how they are powered and maintained. Their mission is to support groundbreaking startups that can reimagine urban living, while significantly reducing carbon emissions and improving sustainability. 2150 primarily invests in Series A and B stage companies, with check sizes ranging from $1 million to $7 million. Their focus spans climate tech, green solutions, and innovative materials, all aimed at creating smarter, more efficient cities. The firm’s portfolio includes companies like CarbonCure, which injects recycled CO₂ into concrete to reduce its carbon footprint, Normative, a platform that helps businesses track and manage their carbon emissions, and Ampd Energy, which electrifies construction sites to minimize pollution. Beyond financial backing, 2150 takes a hands-on approach, working closely with founders to scale their businesses and maximize impact. The firm’s ultimate goal is to build a portfolio capable of mitigating gigatonnes of CO₂ emissions, comparable to the entire annual output of countries like Germany and France. With strong backing from investors like Novo Holdings and the BMW Foundation, 2150 is positioned as a key player in the future of urban development, driving both commercial success and global sustainability.

25madison, established in 2018, is a venture capital firm and startup studio based in New York City. The firm specializes in co-incubating ideas, investing in early-stage startups, and propelling companies into their next growth phase. The venture studio and fund focus on pre-seed to seed-stage investments, particularly in healthcare, fintech, and B2B SaaS sectors. 25madison operates a comprehensive platform that includes a flagship venture studio, a dedicated healthtech studio, and a supply chain studio. This platform supports startups by providing strategic guidance, operational expertise, and capital. The firm prides itself on its bespoke model for early-stage businesses, offering hands-on involvement in business strategy, product development, brand creation, and go-to-market execution. The team at 25madison includes experienced entrepreneurs and investors who bring deep industry knowledge and a track record of building and scaling successful companies. Key team members include Matthew Fremont-Smith, Steven Price, and Michael Lynton. Notable investments from 25madison include companies like Truehold, Pattern, and Handspring Health, which showcase their commitment to transformative products and innovative business models. The firm also collaborates closely with Apollo Global Management, leveraging their network and resources to enhance their startups' growth prospects.

27V (Twenty Seven Ventures) is a venture capital firm that focuses on early-stage investments in EdTech (education technology) and Future of Work startups. The firm was founded by Atin Batra and is headquartered in the Cayman Islands. Since its inception in late 2019, 27V has invested in 28 companies across regions including North America, Europe, and Asia Pacific (excluding India and China). 27V typically invests at the pre-seed and seed stages, with initial checks ranging from $50,000 to $250,000, and reserves funds for follow-on investments. The firm is more than just a fund; it promotes a "Founder Fellowship" that emphasizes community and connections among founders and their teams, facilitating shared learning and support. Notable investments in their portfolio include companies like Fluent, which aims to revolutionize language learning, and Preteckt, which uses machine learning to predict maintenance issues in vehicles. 27V's unique approach includes a scout network that helps identify promising startups from underrepresented communities, fostering diversity and inclusion in the venture capital ecosystem.

37 Angels is an angel investment network founded in 2012, headquartered in New York, NY. The firm is dedicated to closing the gender gap in startup investing by training more women to become angel investors and by investing in high-potential, diverse startups. Each year, 37 Angels evaluates around 2,500 startups and invests in approximately 10, focusing on both male and female-led companies. Their portfolio includes a variety of innovative startups across different sectors. Notable investments include ChalkTalk, an e-learning platform, Partake Foods, a food products company, and EarlyBird, a financial software firm. They also have significant investments in companies like Pulp Pantry, which focuses on sustainable food products, and Sensate, which provides health and wellness solutions. 37 Angels has had multiple successful exits, such as Owlet Baby Care, which went public, and Kinsa Health, which was acquired by a larger firm. Their investment strategy involves supporting startups from early stages through to growth, offering both capital and strategic guidance to help them scale.

3E Bioventures Capital is a prominent venture capital firm specializing in the life sciences sector, focusing on innovative therapeutic drugs and disruptive med-tech. Founded with a mission encapsulated in their name—Expertise, Efficiency, Execution—3E Bioventures actively invests in global health innovators and TechBio, aiming to disrupt conventional paradigms by integrating biology with technology​​. Notable investments include Aravive, which develops biologic drugs targeting tumor metastasis, and C4 Therapeutics, which pioneers small-molecule drugs that degrade disease-causing proteins. Their portfolio also boasts companies like Cytek, which offers a transformative flow cytometry platform, and Twist Bioscience, known for its advanced DNA synthesis technology​​. Geographically, 3E Bioventures operates with a global perspective, maintaining a strong presence in the US and China. They often participate in early-stage and growth-stage investments, providing significant support in both capital and strategic guidance​​. The firm’s team includes experienced professionals such as Li Jing, Frank Yan, and Linda Liu, who leverage their deep industry knowledge to support portfolio companies effectively. They emphasize a science-driven, entrepreneur-friendly approach, working closely with research institutions and companies to address unmet medical needs​. For startups seeking investment, 3E Bioventures looks for breakthrough innovations in biotech and med-tech, focusing on areas with strong medical needs and the potential for significant impact. They prefer to engage with companies that align with their strategic goals and demonstrate a clear pathway to success​​.

3Lines Venture Capital is a Denver-based venture capital firm that was founded in 2016. The firm primarily focuses on early-stage investments in companies leveraging AI and disruptive software technologies, particularly in sectors related to the Future of Work, enterprise solutions, and industry innovations. The firm's investment strategy involves funding startups that are poised to drive significant technological advancements and market transformations. 3Lines has built a robust portfolio that includes notable companies such as Swimlane, a leader in cybersecurity automation, and Arzooo, an Indian retail technology company. Other investments include Aarna Networks in cloud computing and telecommunications, and Tastry, an AI-driven sensory sciences company based in California. 3Lines Venture Capital is known for its strategic approach, often co-investing with other prominent venture capital firms and leveraging a unique investor engagement model that includes managed funds, co-investments, and venture debt. The firm has successfully closed multiple funding rounds, with their second fund closing at $26 million, surpassing the initial target of $20 million. They plan to launch a $100 million Orbit Fund to further expand their investment capabilities. The leadership team at 3Lines includes seasoned professionals with extensive experience in venture capital, technology, and entrepreneurship. Notable members include Hemant Elhence, Operating Partner, and Anil Gupta, Managing Partner for India, both bringing decades of industry expertise to the firm.

3M Ventures, the corporate venture capital arm of 3M, focuses on investing in early-stage companies that align with 3M's strategic priorities. These priorities include automotive electrification, safety, home improvement, consumer electronics, climate tech, sustainable packaging, industrial automation, and semiconductor and data center technologies. Their investment strategy targets companies with strong intellectual property, demonstrated commercial traction, and robust management teams​. Notable investments by 3M Ventures include GrayMatter Robotics, Moxe Health, and Metalenz, which span across artificial intelligence, healthcare, and 3D technology, respectively. 3M Ventures seeks to not only provide financial investment but also leverage 3M's extensive technological platforms, manufacturing capabilities, and global networks to help scale their partner companies​. 3M is also heavily committed to sustainability. The company has pledged $1 billion to achieve carbon neutrality, reduce water use, and improve water quality by 2030. This initiative includes implementing state-of-the-art water purification technology and developing innovative solutions for renewable energy and emissions reduction​.

3one4 Capital is a Bangalore-based early-stage venture capital firm with over $750 million in assets under management. Known for its disciplined investment strategy, the firm has successfully raised $200 million for its latest fund, focusing on technology-driven startups in sectors like SaaS, fintech, consumer internet, and enterprise digitization. Its portfolio includes notable companies such as Licious, Darwinbox, Open, Jupiter, and Koo. The firm was co-founded by Pranav and Siddarth Pai, who lead the charge in identifying and nurturing high-potential startups. They focus on early-stage investments, with typical checks ranging from $500K to $5 million, and offer LPs opportunities for direct co-investment. This deep engagement strategy allows 3one4 to maintain strong portfolio relationships from seed through growth stages. 3one4 also explores newer areas such as climate tech and digital health, aiming to back transformative companies that cater to India’s growing digital economy. With a proven track record of creating unicorns, the firm is one of the top-performing VC funds in India, boasting industry-leading returns. The team includes partners like Anurag Ramdasan and Nruthya Madappa, who bring their expertise to further scale portfolio companies.

3VC is a European venture capital fund that focuses on investing in tech startups with global ambitions, primarily at the Series A stage. They are known for their hands-on support and strong partnerships with founders, offering not only capital but also strategic guidance and connections to help startups grow and succeed. Notable investments by 3VC include simpleclub, an education technology platform; Creatopy, a graphic design platform; Storyblok, a headless CMS platform; and Assaia, which provides AI solutions for airport ground operations. Their approach emphasizes understanding the specific markets their portfolio companies operate in, and they are known for their proactive support throughout the investment process. 3VC was co-founded by Peter Lasinger and Roman Scharf, who bring extensive entrepreneurial and investment experience. The firm is dedicated to investing responsibly and supporting the growth of their portfolio companies with a strong focus on quality partnerships and sustainable development

3x5 Partners is a Portland, Oregon-based venture capital firm that focuses on investments in companies developing solutions for global health and climate challenges. Founded in 2011 by Tony Arnerich and Nicholas Walrod, the firm has raised over $400 million across multiple funds, including their most recent $100 million Fund III. 3x5 Partners primarily invests in late-stage (Series A/B) ventures within sectors such as biotechnology, medical devices, diagnostics, and clean technology. The firm is known for its commitment to long-term partnerships, often leading early investment rounds and providing significant follow-on funding. Notable investments include companies like Fervo Energy, Arch Oncology, and Smart Wires, all of which align with their mission to create meaningful social and environmental impact. 3x5 Partners differentiates itself by focusing on capital-intensive, high-impact ventures that are often overlooked by traditional venture capital firms. They take an active role in the companies they invest in, serving as board members and strategic partners to guide these ventures through critical growth stages. The firm's leadership team, which includes seasoned investors like Joe Biller and David Yeh, is deeply experienced in both impact investing and venture capital, ensuring that they not only generate strong returns for their investors but also contribute to solving some of the world's most pressing problems.

415 Capital is a Munich-based venture capital firm that specializes in investing in breakthrough medical technologies, particularly those addressing critical unmet needs in cardiovascular and neurovascular diseases. With a focus on improving patient outcomes and reducing healthcare costs, 415 Capital invests in startups across Europe, Israel, and North America, typically writing checks between €5 million and €15 million per company. The firm’s portfolio boasts several cutting-edge companies like Supira Medical, which is developing a percutaneous ventricular assist device for high-risk heart patients, and Distalmotion, known for its innovative surgical robotics platform. 415 Capital avoids biotech, healthcare services, and wellness products, honing in exclusively on medtech innovations. Their strategy emphasizes deep involvement from the R&D stage through commercialization, leveraging close relationships with healthcare providers and access to a €2 billion commercial channel in Europe. The firm’s team combines expertise in investment, medical device commercialization, and clinical practice, ensuring they remain at the forefront of medical innovation. Historically, 415 Capital has been part of significant advancements such as the development of transcatheter heart valves and renal denervation technologies. Their approach to venture capital is deeply rooted in the belief that pioneering medical technologies can simultaneously improve healthcare and generate substantial returns.

42CAP, established in 2016 and based in Munich, Germany, is a venture capital firm that focuses on seed-stage investments in B2B technology startups across Europe. The firm is notable for its emphasis on data-driven and SaaS companies, with a strong interest in applications of artificial intelligence and machine learning. Their portfolio includes notable startups like Adverity, a marketing analytics platform, and OnTruck, a real-time marketplace for truck deliveries. 42CAP typically invests between €0.5 million and €1.5 million per company and aims to back ventures that can scale globally from a European base. 42CAP's strategic approach involves partnering with visionary founders to drive technological innovations in B2B sectors. They seek companies that enable organizational agility and efficiency, particularly in fields such as big data and IoT. Their latest fund, totaling €50 million, is set to support approximately 20 startups, expanding on the success of their initial investments. The team behind 42CAP includes experienced entrepreneurs and investors like Alex Meyer and Thomas Wilke, who previously built successful companies such as eCircle and Relayr. This diverse and experienced team is integral to their hands-on approach in supporting portfolio companies from early stages to market leadership.

468 Capital is a venture capital firm headquartered in Berlin and San Francisco, specializing in early-stage investments across various high-tech sectors. Founded in 2020 by Ludwig Ensthaler and Florian Leibert, the firm focuses on technologies that redefine markets, particularly in automation, electrification, software, and consumer/prosumer sectors. Notable investments in their portfolio include companies like Rapid Robotics, Worldcoin, and Superchat, showcasing their interest in innovative and transformative technologies. 468 Capital has made a total of 164 investments, with recent notable exits including natif.ai and Talentspace. The firm's investment strategy is thematic and high-conviction, emphasizing versatility, global reach, and big thinking. This approach is backed by a strong network of founders, operators, and investors, helping portfolio companies grow and achieve significant milestones, including public listings. Their team combines technological expertise with deep market knowledge, enabling them to make agile investment decisions and provide substantial support to their portfolio companies. With offices in Berlin, Madrid, and San Francisco, 468 Capital is well-positioned to support startups in raising global capital, growing teams, and launching products internationally​.

4Di Capital is an early-stage venture capital firm based in Cape Town, South Africa, with a mission to support African entrepreneurs building globally scalable tech solutions. Founded in 2009, 4Di focuses on sectors like fintech, agritech, healthtech, and software, leveraging its deep local expertise and a growing international network. Its notable portfolio includes companies like Aerobotics, LifeQ, and Wasoko, all of which have attracted significant follow-on funding from global investors. The firm primarily invests in seed and post-seed stage startups, particularly those with the potential to expand across Africa and beyond. Their investments are concentrated in Southern and Eastern Africa, but their portfolio spans over 15 countries, including ventures with global ambitions. 4Di's approach combines funding with hands-on mentorship, positioning them as a "nurture capital" firm. They favor close relationships with fewer investors, enhancing their ability to provide tailored support to startups. Recently, 4Di closed a $25 million seed fund, aimed at fueling African tech innovation, especially in undercapitalized markets where there is less competition and better investment opportunities.

4DX Ventures is a prominent venture capital firm dedicated to fostering technological innovation across Africa. Established in 2014, the firm focuses on early to growth-stage investments in diverse sectors, including fintech, e-commerce, healthtech, climate tech, edtech, and logistics. Noteworthy portfolio companies include Andela, Flutterwave, and mPharma, showcasing their commitment to supporting transformative startups on the continent. Geographically, 4DX Ventures has a strong presence in key African markets with offices in Accra, Cairo, and Nairobi. This regional focus allows them to provide robust support and leverage local insights effectively. Their investment strategy is characterized by a deep commitment to partnering with visionary entrepreneurs. They emphasize rigorous due diligence and provide strategic, operational, and technical support to help startups scale. The firm typically leads investment rounds, ensuring substantial backing and ongoing guidance. 4DX Ventures was co-founded by Peter Orth, Walter Baddoo, Daniel Marlo, and Raaid Ahmad, who collectively bring a wealth of experience from prestigious institutions like Morgan Stanley and Bridgewater Associates. The team is dedicated to maintaining high standards of integrity, transparency, and excellence in all their endeavors. Recently, 4DX secured a $10.5 million investment from the International Finance Corporation (IFC) for their third pan-African fund, further solidifying their capacity to drive impactful investments across the continent. Startups are encouraged to approach 4DX with innovative solutions that have the potential for significant impact and scalability.

Founded in 2012, 50 Partners is a Paris-based venture capital firm and startup accelerator. It stands out for its robust support of early-stage companies in the tech, impact, and healthtech sectors. Notable investments include Pixacare, Surge, Wakeo, and Albert. They have achieved successful exits with companies like SimpliField, ProcessOut, and TwicPics. 50 Partners primarily focuses on the French market but has also shown interest in broader European opportunities. Their investment strategy emphasizes early-stage funding, with an average round size of around $2 million. They typically make about seven investments per year and have been particularly active recently, with peak activity in 2022. The team at 50 Partners consists of experienced entrepreneurs and investors, including co-founders Jérôme Masurel, Christophe Berly, Laurent Letourmy, and Rolland Mor. These leaders bring diverse expertise across various industries and business models, providing valuable mentorship to their portfolio companies. For startups looking to engage with 50 Partners, it's crucial to demonstrate strong innovation and scalability potential. They prefer to work closely with founders who are transparent and collaborative, ensuring a good fit with their hands-on approach to nurturing growth.

500 Global, formerly known as 500 Startups, is a prominent venture capital firm with a robust global presence and over $2.4 billion in assets under management. Since its inception in 2010, it has invested in more than 2,800 companies across 80+ countries. Some of its most notable investments include Credit Karma, Twilio, Canva, Grab, Bukalapak, The RealReal, Talkdesk, Udemy, and Ipsy​​. 500 Global's industry focus spans various sectors, with significant investments in consumer services, software-as-a-service (SaaS), fintech, and media​ (Proptech Zone)​. Its geographic focus is truly global, with operations in major innovation hubs such as Silicon Valley, New York, London, Singapore, and Mexico City, as well as emerging markets like Lagos, Jakarta, and Riyadh​​. The fund's strategy involves early-stage investments, providing seed capital along with comprehensive support through its Seed Accelerator Programs. These programs emphasize digital marketing, customer acquisition, lean startup methodologies, and fundraising strategies. 500 Global prefers to invest in companies with high growth potential and innovative business models​. Typically, 500 Global invests an average of $150,000 to $250,000 in initial seed rounds and often leads these rounds. The firm is known for its hands-on approach, leveraging its extensive network of mentors, industry experts, and alumni to support portfolio companies. Recently, 500 Global has been active in launching thematic funds targeting specific industries and regions, further expanding its investment reach​​. The leadership team includes Christine Tsai, the CEO and Founding Partner, who has steered the firm’s growth and global expansion. 500 Global's diverse team of over 100 members spans more than 30 countries, bringing a wealth of experience as entrepreneurs, investors, and operators from leading tech companies​.

574 Invest is the corporate venture capital arm of the SNCF Group, France’s national railway company. Established in 2019 and headquartered in Paris, the fund focuses on early to growth-stage investments in sectors like mobility, Industry 4.0, and climate tech. The fund’s primary mission is to drive innovation in the transportation and industrial sectors, aligning with SNCF’s broader objectives of enhancing sustainable mobility solutions. 574 Invest mainly targets investments in France and Europe, seeking companies that are pioneering new technologies in areas such as micro-mobility, mass transit, and green mobility. The fund leverages SNCF’s extensive industry expertise and resources to offer more than just capital, providing strategic partnerships and access to the company’s vast commercial network. This allows portfolio companies to collaborate closely with SNCF’s various business units, accelerating the development and adoption of their technologies. Some of 574 Invest's notable investments include Electra, which focuses on energy services, and XXII, a company specializing in computer vision technologies. The fund also actively promotes the integration of Industry 4.0 technologies, such as IoT and predictive maintenance, within the transportation sector. 574 Invest's approach is highly strategic, aiming to foster long-term partnerships that can enhance both the SNCF Group's operations and the broader mobility ecosystem.

5AM Ventures, established in 2002, is a prominent venture capital firm specializing in early-stage investments in life sciences. They have a significant presence in both San Francisco and Boston. The firm focuses on biopharmaceuticals, drug delivery technologies, and life science instruments. Their portfolio includes notable companies like Envoy, Epirus, Flexion, Homology Medicines, and Ideaya Biosciences, showcasing their broad impact across the healthcare sector. 5AM Ventures adopts a hands-on approach through their 4:59 Initiative, partnering with academics and entrepreneurs to incubate breakthrough science. They provide both venture capital for private therapeutic companies and public equity investments in small and mid-cap biotech firms. This strategy allows them to support companies from inception through to later stages of development and public offerings. Geographically, 5AM Ventures focuses on investments within the United States, fostering innovation in healthcare by backing companies that address critical medical needs through cutting-edge technology. Their recent exits include companies like Escient Pharmaceuticals and Impel Neuropharma, demonstrating their successful track record. The team at 5AM Ventures includes co-founders Andrew Schwab and John Diekman, along with managing partner Kush Parmar. Their combined expertise in science, medicine, and finance positions them as key players in shaping the future of life sciences. For startups looking to partner with a venture capital firm that offers deep industry knowledge and a robust network, 5AM Ventures presents a compelling opportunity to advance healthcare innovation.

5Y Capital, formerly known as Morningside Venture Capital, is a prominent venture capital firm based in China. Established in 2008 by Richard Liu and Ken Shi, the firm specializes in early-stage investments across a range of sectors including technology, life sciences, digital media, and enterprise IT. With a focus on fostering innovation and supporting visionary entrepreneurs, 5Y Capital manages over $5 billion in assets, sourced from a diverse group of global investors such as sovereign wealth funds, family offices, and endowments. The firm has been an early investor in several notable companies including Xiaomi, Kuaishou, and WeDoctor, helping them scale into industry leaders. 5Y Capital takes a long-term approach, emphasizing deep partnerships with founders and a commitment to being involved from early funding stages through to later growth phases. Their investment philosophy prioritizes groundbreaking ideas that have the potential to disrupt industries, particularly in areas like AI, robotics, and biopharmaceuticals. With offices across Shanghai, Beijing, Shenzhen, and Hong Kong, 5Y Capital is well-positioned to tap into China's rapidly evolving tech landscape while also maintaining a global outlook. They are signatories of the UN Principles for Responsible Investment (UNPRI), underscoring their dedication to sustainable and ethical investing practices. 5Y Capital continues to be a key player in venture capital, supporting entrepreneurs who aim to shape the future of their industries.

645 Ventures, founded in 2014 and based in New York City, is an early-stage venture capital firm known for backing high-growth technology startups. The firm has a strong focus on sectors such as SaaS, digital health, e-commerce, and data infrastructure. Their portfolio includes notable companies like FiscalNote, a platform that helps organizations navigate legislation; Iterable, a cross-channel marketing platform; and Goldbelly, a food delivery service that specializes in regional delicacies. 645 Ventures invests in startups that leverage data to enhance customer experiences, transform traditional industries through software, and innovate within the engineering value chain. They are particularly interested in the second wave of SaaS applications, which address the evolving needs of distributed workforces and the adoption of technology in new business areas. The firm is co-founded by Nnamdi Okike and Aaron Holiday, who bring extensive experience and a hands-on approach to supporting their portfolio companies. This includes helping with customer acquisition, talent recruitment, and fundraising strategy. With a geographic focus primarily in the United States, 645 Ventures also maintains a presence in San Francisco to tap into the West Coast's innovation ecosystem. Their investments range from seed to Series B stages, and they actively lead rounds and provide follow-on funding.

7percent Ventures is a London-based venture capital firm founded in 2014 by ex-founders Andrew Scott and Andrew Gault. Specializing in early-stage investments, the firm focuses on deep-tech startups with transformative potential, often referred to as "moonshot" companies. 7percent Ventures targets industries such as AI, quantum computing, AR/VR, spacetech, and future computing. Their investment philosophy is driven by supporting highly ambitious projects that aim to disrupt entire industries. The firm typically invests at pre-seed, seed, and Series A stages, with a typical investment range of €100,000 to €1.5 million. Notable companies in their portfolio include Oculus VR, which was acquired by Meta, and Universal Quantum, a pioneer in quantum computing. They also have a strong transatlantic reach, with investments spanning both the U.K. and the U.S., particularly in Silicon Valley. 7percent Ventures’ partners bring over 150 years of combined experience as entrepreneurs and investors, offering not just capital but also strategic mentorship, leveraging their extensive networks to help startups scale. The firm emphasizes the importance of transformative innovation and risk-taking in achieving sector-defining success​.

7wireVentures, co-founded by Glen Tullman and Lee Shapiro, is a venture capital firm that invests in early-stage digital health companies. The firm focuses on empowering consumers with innovative health solutions and technologies. Notable investments from 7wireVentures include Livongo, a chronic care management company that was acquired by Teladoc in a significant $18.5 billion deal, and NOCD, which focuses on providing virtual therapy for obsessive-compulsive disorder. Other prominent portfolio companies include FOLX Health, which offers virtual healthcare for the LGBTQIA+ community, and Brightline, a tech-enabled behavioral health platform for children and families. Recently, 7wireVentures closed a $217 million Growth & Opportunity Fund to support their existing portfolio and invest in Series B and C companies. This new fund brings their total assets under management to over $500 million. The firm continues to focus on "consumer-first, tech-enabled health and care solutions," reflecting their commitment to driving the digital transformation of healthcare.

83North is a global venture capital firm with over $2.2 billion in assets under management. Founded in 2006, the firm invests across various stages and sectors, with a focus on supporting exceptional entrepreneurs in building global category-leading companies. The firm operates with a philosophy that emphasizes deep involvement with portfolio companies, long-term relationships, and a lean operational structure, maintained by its four equal partners: Laurel Bowden, Gil Goren, Yoram Snir, and Arnon Dinur. 83North has a significant presence in the US, Europe, and Israel, investing in industries ranging from software and IT to fintech, healthcare, and consumer technology. Notable investments include companies such as Mirakl, Payoneer, Paddle, and Snappy. The firm prides itself on having helped create 14 unicorns and achieving 32 successful exits out of nearly 90 investments. Their investment strategy is grounded in the belief that venture capital is not a scalable business, but rather one that benefits from a focused, hands-on approach. This strategy allows 83North to maintain quick, transparent processes and build a high level of trust with their entrepreneurs.

8capita is a venture capital firm based in Singapore, founded in 2012, that focuses on early-stage investments, particularly at the seed and angel stages. It primarily backs startups in internet, mobile, SaaS, and platform-based businesses, with an emphasis on technology-driven solutions. The firm's investment portfolio includes sectors like enterprise applications, fintech, and consumer tech. Notable investments include Glints, a career development platform, and Jewel Paymentech, which focuses on fintech solutions. 8capita’s geographic reach spans Southeast Asia and the U.S., with investments in Singapore, Malaysia, and the U.S. The firm often co-invests with prominent venture players like 500 Global and Gobi Partners, allowing it to foster a strong network in the startup ecosystem. With a philosophy of supporting high-growth, scalable ventures, 8capita works actively to help its portfolio companies secure follow-on funding and scale operations. The firm has been involved in several acquisitions, including Smarking, acquired by Parkhub, and Jewel Paymentech, reflecting the potential success of its portfolio. With a dedicated team spread across Singapore, Malaysia, and Thailand, 8capita continues to position itself as a key player in the region’s venture capital landscape​.

8VC is a dynamic venture capital firm that focuses on investing in cutting-edge technology and life sciences startups. Notable investments in their portfolio include industry leaders such as Flexport, Guardant Health, Joby Aviation, and Palantir. 8VC primarily targets sectors like healthcare, logistics, IT infrastructure, and defense, with a strong emphasis on transformative technologies that drive significant societal impact. Geographically, 8VC invests globally but has a particular focus on the United States. The firm's investment strategy is centered on early-stage companies, often leading funding rounds with check sizes ranging from $100K to $50M. 8VC is known for its hands-on approach, supporting entrepreneurs not just with capital, but also with deep operational expertise and a robust network. They actively participate in the development of their portfolio companies, sometimes even building companies from the ground up when necessary. Led by Joe Lonsdale, a co-founder of Palantir, 8VC's team includes seasoned professionals with diverse backgrounds in technology, finance, and entrepreneurship. The team operates out of multiple locations, including San Francisco and Austin, positioning them at the heart of the innovation ecosystem. Startups looking to engage with 8VC should be prepared to demonstrate a strong potential for societal impact and innovative technology solutions. The firm values direct, compelling pitches and prefers to be approached through warm introductions within their extensive network.

8X Ventures is a deep-tech-focused venture capital firm established in 2021, with offices in Dubai and significant operations in India. The firm primarily invests in early-stage startups that are driving innovation across sectors like biotechnology, Industry 4.0, clean technology, and advanced computing. 8X Ventures has a strong emphasis on supporting startups that have the potential to disrupt industries and create sustainable value through groundbreaking technologies. In 2023, 8X Ventures expanded its presence in India by opening offices in Delhi and the IIT Research Park in Chennai, reinforcing its commitment to the Indian deep-tech ecosystem. The firm’s investment strategy involves thorough research and a long-term partnership approach, where they don’t just invest but actively collaborate with startups to help them scale. The firm’s portfolio includes around 18 companies, with most of its investments concentrated in India and Southeast Asia. Notable recent investments include Pantherun and XYMA Analytics in India, focusing on high-tech sectors like semiconductors and environmental technology. 8X Ventures recently launched its second fund, a SEBI-registered CAT II fund, with a corpus of ₹200 crore aimed at supporting 18-20 startups in India’s deep-tech sector. The firm’s experienced team, led by Managing Partner Chirag Gupta, is dedicated to identifying and nurturing startups that can lead the next wave of technological innovation​.

9Yards Capital is a San Francisco-based global investment firm focused on growth-stage technology companies, particularly in fintech and logistics. With a strategic emphasis on companies that leverage technology to transform foundational industries, the firm aims to be more than just financial backers. They provide deep industry expertise, particularly in regulatory frameworks, which allows them to offer unique value to their portfolio companies. This includes high-profile investments like Robinhood, Coinbase, Better, and Toast, among others. 9Yards operates across both the U.S. and Europe, targeting investments from early-stage ventures to Series B+ rounds. They typically invest between $100,000 to $10 million, depending on the company's stage and needs. Known for its patient, long-term approach, the firm ensures that its portfolio companies have the resources and connections needed to scale efficiently, often co-investing with other major players in the venture capital landscape. The leadership at 9Yards includes prominent figures such as David Fisher and George Osborne, who bring strong financial and operational expertise. Their team also benefits from the guidance of strategic advisers like Malcolm Turnbull and Admiral Mike Rogers, adding a diverse and influential network that strengthens their ability to impact industries globally. With over $800 million in assets under management, 9Yards Capital continues to be a significant player in shaping the future of technology-driven industries

A Plus Finance, founded in 1998 and headquartered in Paris, is a private equity firm specializing in the management of Common Investment Funds for Innovation (FCPI) and Proximity Investment Funds (FIP). The firm focuses on investing in innovative sectors such as IT, media, security, real estate, audiovisual, industrial, and environmental fields. A Plus Finance's portfolio is diverse, including notable investments in companies like Biotulin, Industrie Ofen Service, and Anotherway. The firm is known for its significant exits, including companies like Adeunis RF, Extruflex, and Intequedis. A Plus Finance typically participates in investment rounds with other co-investors, contributing to the growth and expansion of its portfolio companies. Led by key figures such as co-founder Niels Court-Payen, managing director Fabrice Imbault, and senior partner Hervé Legoupil, the firm leverages its extensive industry expertise to support the development and scaling of innovative businesses. Their investment strategy focuses on sectors that promise high growth potential and transformative impact, ensuring a robust and dynamic portfolio.

A.Capital Ventures, co-founded by Ronny Conway and Ramu Arunachalam, focuses on providing strategic investments and support to early-stage startups. Based in the US, A.Capital is noted for its flexible investment approach, allowing startups to grow without significant dilution or stringent ownership thresholds. They prioritize high-potential sectors like AI, blockchain, and enterprise software. A.Capital's portfolio includes notable companies like Notion, Airbnb, and Coinbase, showcasing their strength in backing transformative technologies. The firm offers more than just capital; they provide valuable connections, world-class advice, and access to top talent, thanks to their partners' extensive experience at Google and other tech giants. A.Capital avoids traditional board seat requirements, instead fostering a collaborative partnership with founders. This unique model has enabled startups to scale effectively, leveraging the firm's resources and networks without compromising control. Entrepreneurs can approach A.Capital through their network of referrals or by directly engaging with their team during industry events. With a clear focus on building the future through innovation and a hands-on investment strategy, A.Capital Ventures stands out as a pivotal supporter of groundbreaking startups across various tech-driven industries​.

A-Star is a dynamic investment firm that excels in scaling early-stage companies with significant growth potential. The firm’s strategy revolves around providing both capital and strategic support, ensuring that startups can transition from promising ideas to thriving businesses. A-Star is deeply committed to fostering long-term partnerships, taking a hands-on approach in guiding companies through critical growth stages. The firm’s team boasts a wealth of experience in entrepreneurship, finance, and venture capital, enabling them to identify and nurture innovative businesses across a wide range of sectors. This expertise allows A-Star to build a diverse portfolio of transformative companies, each poised to make a substantial impact in their respective industries. With a keen focus on sustainable growth and long-term success, A-Star partners with entrepreneurs who share a vision for innovation and excellence. Through their dedicated involvement, A-Star helps these companies navigate the complexities of scaling, providing the necessary tools and resources to achieve market leadership. The firm’s approach is characterized by its emphasis on collaboration and its commitment to the sustained success of its portfolio companies. By leveraging their extensive network and industry insights, A-Star not only supports the growth of individual companies but also contributes to the broader entrepreneurial ecosystem. Their mission is to empower visionary founders and turn high-potential startups into market-leading enterprises, driving meaningful change and creating lasting value.

a16z Crypto is the cryptocurrency-focused arm of Andreessen Horowitz, one of the most prominent venture capital firms. Launched in 2018, the fund is dedicated to investing in crypto and Web3 startups across various stages of growth. With a long-term focus, a16z Crypto supports projects that are building the future of decentralized technologies, including blockchain infrastructure, decentralized finance (DeFi), NFTs, and cryptocurrency exchanges. The firm takes a patient investment approach, aiming to hold investments for 10+ years and committing to continuous funding, even during market downturns. A16z Crypto's portfolio includes major players like Coinbase, Uniswap, Chainlink, and Dfinity, showcasing its focus on transformative technologies that can redefine financial services, digital ownership, and the internet itself. a16z Crypto provides more than just capital. It offers extensive operational support to its portfolio companies, including help with recruiting, regulatory affairs, and marketing. The fund actively participates in governance, often taking board seats to guide projects strategically. With over $7.6 billion in committed capital across multiple funds, a16z Crypto is well-positioned to be a major force in the evolving blockchain ecosystem.

AAF Management Ltd., founded in 2016 and headquartered in Washington, D.C., is a prominent early-stage venture capital firm. The firm focuses on pre-seed, seed, and Series A stage technology companies in North America, with particular emphasis on sectors such as fintech, healthcare, consumer tech, enterprise software, and deep tech. AAF Management has an impressive portfolio of over 120 venture-backed companies. Notable investments include Robinhood, Didi, Savage X Fenty, StockX, Figure, Reddit, Current, Synthego, Jasper, and Drata. The firm has also celebrated significant exits, such as CrowdStrike (NASDAQ: CRWD), TruOptik (acquired by TransUnion), Even Financial (acquired by MoneyLion), Prodigy (acquired by Upstart), Portfolium (acquired by Instructure), and HeyDoctor (acquired by GoodRx). The firm is backed by over 95 limited partners, including family offices, royal families, C-level executives, and hedge fund managers from the US, Europe, and MENA regions. AAF Management prides itself on its strategic value-add, leveraging a vast network to support its portfolio companies and emerging managers globally.

Abacus Alpha, founded in 2006 and based in Germany, is a prominent investment firm specializing in medium-sized, technology-driven companies across various sectors, including industrial, trade, and services. The firm’s core focus is on fostering sustainable growth and innovation, with a particular emphasis on industries such as automation, cleantech, innovative materials, and advanced production processes. Abacus Alpha is committed to long-term partnerships, working closely with portfolio companies to drive strategic development while allowing management teams the autonomy to manage day-to-day operations. This hands-off approach is paired with a strong emphasis on collaboration, where the firm provides strategic support and resources to help companies achieve their full potential. Abacus Alpha believes in creating synergies within its portfolio, aiming to build a network of companies that can leverage each other's strengths to drive growth and innovation. The firm's investment philosophy is rooted in the belief that sustainable value is created through careful selection of opportunities, targeted expansion, and diversification. Abacus Alpha seeks out companies with strong market positions and the potential for significant growth, investing not just capital but also expertise to help them scale effectively. By focusing on long-term value creation rather than short-term gains, Abacus Alpha has built a reputation as a reliable and forward-thinking partner in the German and European investment landscape. The firm’s approach has made it a key player in driving technological advancement and economic growth within the sectors it targets.

ABB is a global leader in electrification, automation, robotics, and motion technologies, aiming to drive sustainable industrial transformations. Headquartered in Switzerland, ABB operates in over 100 countries and employs around 105,000 people. Their solutions focus on increasing energy efficiency and improving productivity across a wide range of industries, from utilities and transport to infrastructure and manufacturing. ABB’s business is organized into four key areas: Electrification, Motion, Robotics & Discrete Automation, and Process Automation. These divisions help industries across the globe innovate and optimize their processes. For example, ABB's Robotics division is one of the world’s leading providers of robotics and machine automation solutions, integrating advanced technologies like AI and the Internet of Things (IoT) to support smarter factories. In addition to their core business, ABB is deeply involved in sustainability efforts. They are committed to reducing carbon emissions and supporting the transition to renewable energy, as seen in their contributions to electric vehicle (EV) infrastructure and sustainable transport solutions. ABB has partnered with organizations such as NASCAR to explore electrification in motorsports, furthering innovation in high-performance electric racing vehicles. The company’s strong focus on research and development has led to cutting-edge innovations, particularly in electrification, where they design energy-efficient solutions to power cities and industries sustainably. ABB's global footprint and long-standing commitment to innovation make them a key player in driving the future of industrial automation and clean energy.

Abies Ventures is a Tokyo-based venture capital firm that specializes in deep tech investments, aiming to tackle global issues like environmental degradation and food shortages through science and advanced technologies. Established in 2017, the firm focuses on early-stage companies with innovative solutions in areas such as AI, robotics, quantum computing, and biotech. Their portfolio includes cutting-edge startups like Synspective, Telexistence, and Mighty Buildings, reflecting their commitment to building sustainable, tech-driven solutions. Abies Ventures leverages its strong global network, partnering with large corporations, research institutes, and government agencies to help startups scale internationally. The fund is led by experienced venture founders like Fuyuki Yamaguchi and Sota Nagano, who bring extensive expertise in venture investment and scaling companies across Japan and the U.S. Their investment strategy centers on fostering deep tech companies with high impact potential, particularly in areas where finance, technology, and market dynamics may not always align. Abies Ventures helps bridge these gaps by providing strategic advice and connecting startups with key players to enhance their growth trajectory​.

Abingworth, founded in 1973, is a transatlantic life sciences investment firm with a robust portfolio and a strategic focus on turning innovative science into transformative medical treatments. With offices in London, Boston, and San Francisco, Abingworth has invested in over 179 companies, resulting in 73 IPOs and 46 M&As. The firm operates across three main investment stages: seed and early-stage, development stage, and clinical co-development, and typically invests between $500,000 to $2 million in initial rounds, supporting portfolio companies through subsequent funding stages. Notable investments include Adaptate Biotherapeutics, Jasper, and Tizona Therapeutics. Abingworth's team, led by Managing Partners Tim Haines and Kurt von Emster, brings decades of experience in life sciences and venture capital. The firm is deeply embedded in key biotech hubs, facilitating productive interactions with entrepreneurs and access to top-tier scientific talent. The firm emphasizes long-term partnerships, providing not just capital but also strategic guidance in areas such as clinical development, regulatory approval, and commercialization. Abingworth's recent integration with Carlyle Group underscores its commitment to expanding its impact in the global healthcare investment ecosystem. Startups seeking investment from Abingworth should have groundbreaking science with the potential to materially improve patient outcomes. The firm values deep industry expertise, strong leadership, and a clear path to transformative impact.

Able Partners, founded in 2016 and based in New York City, is a venture capital firm that focuses on investing in early-stage companies aiming to improve daily lives through health and wellness. The firm is known for its support of passionate entrepreneurs and inspiring brands across various industries including consumer products, health tech, and wellness. Their diverse portfolio includes investments in companies such as Clare, a direct-to-consumer paint company; Alto Neuroscience, a company focused on precision psychiatry; Little Otter, a mental health service for children and families; and Kindred, a network for professional caregivers. Other notable investments are Beam Impact, Vivvi, and Capable Health. Able Partners has made over 60 investments and has achieved multiple successful exits. Key exits include Alto Neuroscience, Stretch*d, and Capable Health, showcasing their ability to support companies from early stages to successful outcomes. The firm is led by co-founders Lisa Blau and Amanda Eilian, who bring extensive experience in consumer-focused investments and entrepreneurship. Their investment strategy emphasizes not only providing capital but also leveraging their extensive networks and expertise to help portfolio companies achieve their full potential.

ABN AMRO Ventures, the corporate venture arm of ABN AMRO Bank, operates with €150 million under management, focusing on fintech, regtech, and sustainability-oriented tech solutions. Their investments emphasize scaling startups that bolster financial services through AI, blockchain, data analytics, and innovative SaaS models. With a strategic geographic focus on Europe, they selectively branch out to North America and Israel. Their strategy aims to bridge the banking ecosystem with cutting-edge solutions, preferring Series A and later-stage rounds with investments ranging from €2 to €15 million. ABN AMRO Ventures often co-invests but does not always lead rounds, positioning itself as a value-added participant that extends industry insights and networking opportunities. The fund boasts a strong portfolio, including prominent names like Tink, Quantexa, and solar finance enabler Laka. They prioritize partnerships that align with the bank's broader objectives of innovation and sustainability. The team, steered by Managing Director Hugo Bongers and a group of seasoned financial and tech experts based in Amsterdam, emphasizes accessible communication with founders and appreciates clear, data-driven pitches. Startups are advised to demonstrate robust market potential, scalable technology, and strategic alignment with banking needs to capture their interest. ABN AMRO Ventures actively engages in fostering innovation hubs and prefers targeted, well-researched approaches when founders seek to initiate contact.

Abstract Ventures is a San Francisco-based VC firm founded in 2016, focusing on early-stage investments across biotech, consumer products, crypto, and enterprise frontier tech. The firm has gained a reputation for backing innovative and high-potential startups, with a portfolio that includes successes like Rippling and Material, the latter achieving unicorn status in 2022. Abstract Ventures primarily targets investments within the U.S., engaging in Seed and Series A rounds with typical check sizes ranging from $5 to $15 million. Their strategy blends flexibility with strategic partnerships, often co-investing with other VCs and leading rounds when they see transformative potential. Abstract is known for being founder-friendly, offering not just capital but also access to a wide network of industry experts, experienced entrepreneurs, and investors who can provide significant strategic value. In 2024, Abstract maintained a proactive stance, completing 16 new investments in companies such as Unify and Thirddimension.ai. The firm’s small yet powerful team is spearheaded by founder and General Partner Ramtin Naimi, who, along with four other partners, leverages years of investment experience and market insight from their base in San Francisco. Abstract Ventures advises founders to approach with a robust market strategy, proven product traction, and genuine storytelling. Rather than solely evaluating polished decks, the firm seeks authenticity and conviction in a startup’s vision. They primarily source deals through referrals and their network, emphasizing relationships and strategic alignment. With this approach, Abstract has carved out a distinctive presence in the early-stage VC landscape, empowering founders from idea to growth phase.